Cancer stem cell definitions and terminology: the devil is in the details

Giorgio Stassi, Mhairi Copland, Harald Herrmann, Sabine Cerny-Reiterer, Michael Andreeff, Peter Valent, Michel Arock, Dominique Bonnet, Stefan Wöhrer, Brian Huntly, Jan Jacob Schuringa, Giorgio Stassi, Alexander Roesch, Gerrit Jan Schuurhuis, Tsvee Lapidot, Johannes Zuber, Michel Arock, Christine Chomienne, Connie Eaves, Jean SoulierFumihiko Ishikawa, Junia V. Melo, Hans E. Johnsen, Ruggero De Maria

Risultato della ricerca: Articlepeer review

441 Citazioni (Scopus)


The cancer stem cell (CSC) concept has important therapeutic implications, but its investigation has been hampered both by a lack of consistency in the terms used for these cells and by how they are defined. Evidence of their heterogeneous origins, frequencies and their genomic, as well as their phenotypic and functional, properties has added to the confusion and has fuelled new ideas and controversies. Participants in The Year 2011 Working Conference on CSCs met to review these issues and to propose a conceptual and practical framework for CSC terminology. More precise reporting of the parameters that are used to identify CSCs and to attribute responses to them is also recommended as key to accelerating an understanding of their biology and developing more effective methods for their eradication in patients.
Lingua originaleEnglish
pagine (da-a)767-775
Numero di pagine9
RivistaNature Reviews Cancer
Stato di pubblicazionePublished - 2012

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2730???
  • ???subjectarea.asjc.1300.1306???


Entra nei temi di ricerca di 'Cancer stem cell definitions and terminology: the devil is in the details'. Insieme formano una fingerprint unica.

Cita questo